Results 161 to 170 of about 19,999 (193)

Comparative thromboembolic risk of romiplostim versus eltrombopag in immune thrombocytopenia: a propensity score-matched cohort study. [PDF]

Ann Hematol
Shah A, Gor R, Kra J.
europepmc   +1 more source

Novel Thrombopoietin-Mimetic Peptide 2B9F: A Promising Therapeutic Candidate for Hematopoietic Acute Radiation Syndrome. [PDF]

ACS Omega
Yu K, Shu H, Zhu W, Shen X, Xing S, Xiao H, Yu Z.   +6 more
europepmc   +1 more source

The thrombotic burden of high-risk immune thrombocytopenia patients receiving second-line treatments: a systematic review. [PDF]

Rheumatology (Oxford)
Tarasconi E, Clerici B, Marcucci G, Pontisso E, Mondini C, Pisetta C, Birocchi S, Schioppo T, Podda GM.   +8 more
europepmc   +1 more source

Immune-related pancytopenia in pregnancy. [PDF]

Intern Med J
Su Z, Xu J, Cui H.
europepmc   +1 more source

Emerging targeted therapies for primary immune thrombocytopenia: novel agents, combination strategies, and future directions. [PDF]

Front Pharmacol
Wang Z, Yang W, Xu N, Ma L, Wang A, Liu B.   +5 more
europepmc   +1 more source

Successful Treatment of Evans Syndrome Onset With Zanubrutinib in Combination With Romiplostim During Venetoclax Treatment in a Patient With Chronic Lymphocytic Leukemia: A Case Report. [PDF]

Clin Case Rep
Innao V, Barbagallo APM, Bianco O, Leotta V, Consoli U.   +4 more
europepmc   +1 more source

Unintended First-Trimester Exposure to Two Distinct Thrombopoietin Receptor Agonists in Consecutive Pregnancies Without Maternal or Fetal Harm [PDF]

Turk J Haematol
Köseoğlu FD, Kum A.
europepmc   +1 more source

Romiplostim in the management of severe aplastic anemia: a comprehensive clinical review. [PDF]

Ann Hematol
Mohammed Saleh MF, Nasiri A, Kotb A, Alfadil H, Alzahrani H, Aljurf M, Alahmari A.   +6 more
europepmc   +1 more source